All the news Showing 10 of 39 articles from: SpainGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Treatment for people living with HIV and HCV People with HIV/HCV co-infection see good cure rates in real-world practice in Madrid Liz Highleyman / 22 November 2016 More than 90% of HIV-positive people treated with direct-acting antivirals for hepatitis C – including many with liver cirrhosis – achieved sustained virological response and few discontinued treatment due to side-effects, showing that ... Treatment for people living with HIV and HCV Does having HIV affect response to hepatitis C treatment? Liz Highleyman / 16 May 2016 A study from the US Veterans Health Administration found that HIV-positive people responded as well as those without HIV to direct-acting antiviral (DAA) therapy for hepatitis C, while a Spanish study showed that ... Treatment in cirrhosis Hepatitis C treatment may not be enough to stop the progress of advanced liver disease, or reduce liver transplant need Keith Alcorn / 14 April 2016 Doctors need to have “full and frank” discussions with patients about the potential risks and benefits of using direct-acting antivirals to treat hepatitis C in late-stage liver disease, especially among those waiting for ... Sofosbuvir/daclatasvir combination could be produced for $200 per cure Keith Alcorn / 14 December 2015 Month-by-month tracking of the prices paid in India for the chemicals used to make hepatitis C direct-acting antivirals shows that it is now possible to make and sell a combination of drugs ... Treatment outcomes Liver fibrosis regression after hepatitis C treatment linked to reduced complications and death in people with HIV and HCV co-infection Liz Highleyman / 06 August 2015 People with HIV and HCV co-infection, with liver cirrhosis, who achieve sustained virological response (SVR) and experience an improvement in liver fibrosis are less likely to develop liver disease complications or die from ... Hepatitis delta Hepatitis delta virus co-infection increases risk of poor liver-related outcomes for people living with HIV Michael Carter / 07 April 2014 Co-infection with hepatitis delta virus (HDV) is a major risk factor for hepatic decompensation and liver-related death in people living with HIV, Spanish investigators report in the online edition of Clinical Infectious Diseases. Over ... Treatment for people living with HIV and HCV Interferon response reduces liver disease and death in people with HIV/HCV co-infection Liz Highleyman / 19 September 2013 Effective interferon-based therapy that produces sustained virological response led to significant reductions in liver decompensation, HIV disease progression and both overall and liver-related mortality among people with HIV and hepatitis C co-infection, according ... Treatment for people living with HIV and HCV People with HIV/HCV co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease Michael Carter / 10 September 2013 People living with HIV who have hepatitis C virus (HCV) co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease even though they do not have cirrhosis of the liver, ... HIV Triple trouble: infection with hepatitis B increases risk of death for people with HIV and hepatitis C co-infection Michael Carter / 19 February 2013 Infection with hepatitis B virus (HBV) is associated with a poorer prognosis for people living with HIV who are co-infected with hepatitis C virus (HCV), Spanish investigators report in a study published in ... HIV Spanish research shows that liver stiffness can predict outcomes in people co-infected with HIV and hepatitis C Michael Carter / 30 January 2013 Liver stiffness is a strong predictor of hepatic complications and all-cause mortality in people co-infected with HIV and hepatitis C virus (HCV), Spanish investigators report in the online edition of AIDS. Liver ... ← Prev1234Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive